Is semaglutide the same as Ozempic?

Ingredient, brand, product

A medicine has an active ingredient, the substance that does the work, and usually a brand name. The Ozempic® label describes its injection as a solution of semaglutide, a GLP-1 receptor agonist whose peptide backbone is produced by yeast fermentation ^[1].

So every Ozempic® pen contains semaglutide, but not every product containing semaglutide is Ozempic®. A brand stands for one approved formulation, its devices and strengths, the controls on how it is made, and its own label, the document that sets out who it is for and how it is used.

Even the injections differ in what surrounds the molecule. In both brands, the multi-dose pens contain phenol and propylene glycol, while the single-dose pens and syringes use sodium chloride in their place ^[1][3]. The tablets add an absorption enhancer called SNAC (salcaprozate sodium) and magnesium stearate; Rybelsus® tablets also contain microcrystalline cellulose and povidone ^[2][3].

Every approved semaglutide product, side by side

In the US, five products carry semaglutide under three brand names. The table lists them with the same four headings, each taken from that product’s own label ^[1][2][3].

Why a milligram number does not travel

Because the same molecule enters the body in different ways, the dose printed on one product says little about another. The injection labels give an absolute bioavailability of 89% under the skin, with the highest level 1 to 3 days after a dose ^[1][3]. The tablet label estimates 0.4% to 1% for Rybelsus® and 1% to 2% for Ozempic® tablets, with a peak about an hour after swallowing ^[2].

That is why the tablet label reports that the older Rybelsus® strengths and the newer Ozempic® tablet strengths reached similar blood levels at different milligram numbers, and why it forbids treating them as interchangeable ^[2]. The Ozempic® injection label describes weekly maintenance doses up to 2 mg, while the Wegovy® label lists weekly pens up to 7.2 mg and daily tablets up to 25 mg ^[1][3].

None of this is a conversion chart. The labels describe only a few named switches, such as between Wegovy® injection and tablets or from Ozempic® injection to the tablets, and none between Ozempic® and Wegovy®; the Wegovy® label also says it should not be combined with other semaglutide-containing products ^[1][2][3]. Any change from one product to another is planned by your prescriber.

Same molecule, different rules

• Breastfeeding: the tablet label advises against breastfeeding on Rybelsus® or Ozempic® tablets because SNAC and its breakdown products pass into breast milk, and notes that semaglutide products without SNAC exist ^[2].
• Taking it: tablets are swallowed whole each morning on an empty stomach with water, up to 4 ounces, then a 30-minute wait before food, drinks or other oral medicines; injections can be given at any time of day ^[1][2].
• Missed doses: a missed Ozempic® injection can still be given within 5 days, while a missed tablet is skipped until the next day ^[1][2].
• Region: in the EU, the 1.5, 4 and 9 mg tablet strengths are sold under the Rybelsus® name together with 25 and 50 mg, and the Ozempic® product information there lists type 2 diabetes as its only indication, with heart and kidney trial results described separately ^[7][8].

Compounded semaglutide is not Ozempic

Compounding means a pharmacy prepares a drug for a patient. The FDA states that compounded drugs are not FDA-approved, so the agency does not check their safety, effectiveness or quality before they are sold ^[4][5]. A compounded drug is not a generic either: a generic is approved under a separate legal pathway that requires it to be shown therapeutically equivalent to the brand ^[5].

The FDA lists as a red flag any company claiming its compounded drug is the same as an FDA-approved one. It also reports that some compounders have sold salt forms such as semaglutide sodium and semaglutide acetate, which are different active ingredients from the one in the approved drugs, and says it knows of no lawful basis for compounding with them ^[4].

The agency describes two further problems. Some products labelled as compounded semaglutide named pharmacies that do not exist or that never made them. And it has received reports, some involving hospital care, linked to dosing errors when patients measured their own doses from compounded products, or when professionals miscalculated them ^[4].

Counterfeit and “research” products

The FDA reports counterfeit Ozempic® in the US, which could contain the wrong ingredients, too little or too much active ingredient, or none at all. It has also warned companies selling semaglutide falsely labelled “for research purposes” or “not for human consumption” directly to consumers with dosing instructions ^[4].

As of 31 May 2026, the FDA had received 990 adverse event reports associated with compounded semaglutide. It notes that pharmacies that are not outsourcing facilities do not have to report adverse events, so such reports are likely incomplete, and that a cause cannot always be established ^[4].

What to check on your own medicine

The labels give a few checks you can make at home. Ozempic® and Wegovy® injections should be clear and colourless; the Ozempic® label says not to use a pen if you see particles or colouring ^[1][3]. Semaglutide tablets are white to light yellow and debossed with their strength on one side and “novo” on the other; Rybelsus® tablets are oval, Ozempic® tablets round, and Wegovy® tablets round except the oval 25 mg ^[2][3].

The brand name, the strength and the form should match your prescription. The FDA advises filling prescriptions at a state-licensed pharmacy, and lists medicine that looks different from what you received before, or packaging that is damaged or missing its instructions, as warning signs ^[4]. MedlinePlus lists Ozempic®, Wegovy® and Wegovy® HD as brand names of semaglutide injection ^[6].

Questions worth asking your pharmacist

• Is this a brand-name product, a generic or a compounded preparation, and who made it ^[4][5]?
• Is the active ingredient semaglutide itself, or a salt form such as semaglutide sodium or acetate ^[4]?
• Which strength is this, and how does it relate to the dose my prescriber wrote, given that milligrams differ between forms ^[2]?
• If I am changing products, which one do I stop, when, and is the first dose of the new one a starting dose ^[1][2][3]?

Ozempic®, Wegovy® and Rybelsus® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help